NOVOVANCE Trademark

Trademark Overview

On Wednesday, September 21, 2011, a trademark application was filed for NOVOVANCE with the United States Patent and Trademark Office. The USPTO has given the NOVOVANCE trademark a serial number of 79104553. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, September 21, 2021. This trademark is owned by Novo Nordisk Health Care AG. The NOVOVANCE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for haemostasis management
novovance

General Information

Serial Number79104553
Word MarkNOVOVANCE
Filing DateWednesday, September 21, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, September 21, 2021
Registration Number4120262
Registration DateTuesday, April 3, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for haemostasis management
Pseudo MarkNOVO VANCE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk Health Care AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Saturday, April 16, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, April 16, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, August 6, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, November 30, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, August 7, 2019TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, August 7, 2019INVALIDATION PROCESSED
Tuesday, July 9, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, November 9, 2018CANCELLED SECTION 71
Thursday, November 1, 2012NOTIFICATION PROCESSED BY IB
Saturday, October 6, 2012NOTIFICATION PROCESSED BY IB
Monday, September 10, 2012FINAL DISPOSITION NOTICE SENT TO IB
Monday, September 10, 2012FINAL DISPOSITION PROCESSED
Thursday, May 3, 2012GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, April 3, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, January 17, 2012PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 28, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 28, 2011NOTICE OF PUBLICATION
Tuesday, December 6, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 5, 2011ASSIGNED TO EXAMINER
Friday, November 25, 2011APPLICATION FILING RECEIPT MAILED
Monday, November 21, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 17, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

novovance management haemostasis preparations pharmaceutical